ARIPiprazole - Latest Advances

Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics.

Journal: The Journal of clinical psychiatry

Published: December 15, 2025

Management of schizophrenia patients in acute setting - a multinational survey of prescription patterns in five European countries.

Journal: International journal of psychiatry in clinical practice

Published: December 14, 2025

Rapid treatment initiation in patients with schizophrenia: evaluation of the clinical and functional outcomes of the two-injection start regimen of aripiprazole once-monthly.

Journal: International journal of psychiatry in clinical practice

Published: December 12, 2025

Association of propranolol with treatment-emergent akathisia during aripiprazole treatment.

Journal: Ideggyogyaszati szemle

Published: December 01, 2025

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine and Risperidone in Alzheimer's Disease: A Real□World Cohort Study with Treatment Effect Heterogeneity Analysis.

Journal: medRxiv : the preprint server for health sciences

Published: November 26, 2025

Aripiprazole in the treatment of psychiatric disorders in childhood

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: November 24, 2025

Clinical outcomes and serum prolactin levels in patients with antipsychotic-induced hyperprolactinemia following different management strategies.

Journal: International journal of psychiatry in clinical practice

Published: November 24, 2025

Effect of aripiprazole and improved living conditions on behavioral manifestations and neurogenic markers expression in an animal model of PTSD.

Journal: Endocrine regulations

Published: November 11, 2025

Aripiprazole and breastfeeding: A retrospective, multi-site, case series.

Journal: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists

Published: November 10, 2025

Prevention of prolactin reduction: a novel strategy countering multi-generational growth retardation caused by maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Journal: The Journal of toxicological sciences

Published: November 03, 2025

Pharmacokinetic modeling and simulation of a two-injection start with aripiprazole once-monthly in people living with schizophrenia: a plain language summary.

Journal: Current medical research and opinion

Published: November 01, 2025

Sexual reactivation under aripiprazole in schizophrenia: a note for prescribers.

Journal: Journal of psychiatry & neuroscience : JPN

Published: October 31, 2025

Filters

Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics.

Obstetric Outcomes With Second-Generation Long-Acting Injectable Versus Oral Antipsychotics.

Management of schizophrenia patients in acute setting - a multinational survey of prescription patterns in five European countries.

Management of schizophrenia patients in acute setting - a multinational survey of prescription patterns in five European countries.

Rapid treatment initiation in patients with schizophrenia: evaluation of the clinical and functional outcomes of the two-injection start regimen of aripiprazole once-monthly.

Rapid treatment initiation in patients with schizophrenia: evaluation of the clinical and functional outcomes of the two-injection start regimen of aripiprazole once-monthly.

Association of propranolol with treatment-emergent akathisia during aripiprazole treatment.

Association of propranolol with treatment-emergent akathisia during aripiprazole treatment.

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine and Risperidone in Alzheimer's Disease: A Real□World Cohort Study with Treatment Effect Heterogeneity Analysis.

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine and Risperidone in Alzheimer's Disease: A Real□World Cohort Study with Treatment Effect Heterogeneity Analysis.

Aripiprazole in the treatment of psychiatric disorders in childhood

Aripiprazole in the treatment of psychiatric disorders in childhood

Clinical outcomes and serum prolactin levels in patients with antipsychotic-induced hyperprolactinemia following different management strategies.

Clinical outcomes and serum prolactin levels in patients with antipsychotic-induced hyperprolactinemia following different management strategies.

Effect of aripiprazole and improved living conditions on behavioral manifestations and neurogenic markers expression in an animal model of PTSD.

Effect of aripiprazole and improved living conditions on behavioral manifestations and neurogenic markers expression in an animal model of PTSD.

Aripiprazole and breastfeeding: A retrospective, multi-site, case series.

Aripiprazole and breastfeeding: A retrospective, multi-site, case series.

Prevention of prolactin reduction: a novel strategy countering multi-generational growth retardation caused by maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Prevention of prolactin reduction: a novel strategy countering multi-generational growth retardation caused by maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Pharmacokinetic modeling and simulation of a two-injection start with aripiprazole once-monthly in people living with schizophrenia: a plain language summary.

Pharmacokinetic modeling and simulation of a two-injection start with aripiprazole once-monthly in people living with schizophrenia: a plain language summary.

Sexual reactivation under aripiprazole in schizophrenia: a note for prescribers.

Sexual reactivation under aripiprazole in schizophrenia: a note for prescribers.